Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024
Vicarious Surgical (NYSE: RBOT) has announced it will release its third quarter 2024 financial results on November 12, 2024, after market close. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the results. Investors can join via phone by dialing +1 833-470-1428 (domestic) or +1 404-975-4839 (international) using access code 246564. A webcast will be available on the company's investor relations website.
Vicarious Surgical (NYSE: RBOT) ha annunciato che pubblicherà i suoi risultati finanziari del terzo trimestre 2024 il 12 novembre 2024, dopo la chiusura del mercato. L'azienda organizzerà una conference call alle 16:30 ora orientale per discutere i risultati. Gli investitori possono partecipare telefonicamente componendo +1 833-470-1428 (nazionale) o +1 404-975-4839 (internazionale) utilizzando il codice di accesso 246564. Una webchat sarà disponibile sul sito delle relazioni con gli investitori dell'azienda.
Vicarious Surgical (NYSE: RBOT) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el 12 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a las 4:30 p.m. hora del Este para discutir los resultados. Los inversores pueden unirse por teléfono marcando +1 833-470-1428 (doméstico) o +1 404-975-4839 (internacional) utilizando el código de acceso 246564. Se dispondrá de una transmisión web en el sitio web de relaciones con los inversores de la compañía.
비카리어스 서지컬(Vicarious Surgical, NYSE: RBOT)은 2024년 3분기 재무 결과를 2024년 11월 12일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 결과를 논의하기 위해 동부 표준시 기준 오후 4시 30분에 콘퍼런스 콜을 개최합니다. 투자자들은 +1 833-470-1428 (국내) 또는 +1 404-975-4839 (국제)로 전화하여 액세스 코드 246564를 사용하여 참여할 수 있습니다. 회사의 투자자 관계 웹사이트에서 웹캐스트를 이용할 수 있습니다.
Vicarious Surgical (NYSE: RBOT) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le 12 novembre 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique à 16h30, heure de l'Est, pour discuter des résultats. Les investisseurs peuvent se joindre par téléphone en composant le +1 833-470-1428 (domestique) ou le +1 404-975-4839 (international) en utilisant le code d'accès 246564. Un webinaire sera disponible sur le site web des relations investisseurs de l'entreprise.
Vicarious Surgical (NYSE: RBOT) hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 am 12. November 2024 nach Börsenschluss veröffentlichen wird. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können sich telefonisch unter +1 833-470-1428 (national) oder +1 404-975-4839 (international) mit dem Zugangscode 246564 einwählen. Ein Webcast wird auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 246564. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com.
About Vicarious Surgical
Founded in 2014, Vicarious Surgical is a next generation surgical robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241029085382/en/
Investor
Kaitlyn Brosco
Vicarious Surgical
Kbrosco@vicarioussurgical.com
Media Inquiries
media@vicarioussurgical.com
Source: Vicarious Surgical Inc.
FAQ
When will Vicarious Surgical (RBOT) report Q3 2024 earnings?
How can I listen to Vicarious Surgical's (RBOT) Q3 2024 earnings call?